Savaysa and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Savaysa (edoxaban tosylate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Myrbetriq, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Weakness when taking Savaysa. It is created by eHealthMe based on reports of 947 people who have side effects when taking Savaysa from the FDA, and is updated regularly.

What is Savaysa?

Savaysa has active ingredients of edoxaban tosylate. eHealthMe is studying from 967 Savaysa users. Check the latest studies of Savaysa.

What is Weakness?

Weakness is found to be associated with 3,638 drugs and 6,617 conditions by eHealthMe. Check the latest studies of Weakness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

947 people reported to have side effects when taking Savaysa.
Among them, 22 people (2.32%) have Weakness.

Among these 22 people:

How long have people been on Savaysa when they have Weakness? *

What is the gender of people who have Weakness when taking Savaysa? *

female: 12.5 %
male: 87.5 %

What is the age of people who have Weakness when taking Savaysa? *

What are other drugs people take besides Savaysa? *

What are other side effects people have besides Weakness? *

Fatigue (feeling of tiredness): 12 people, 54.55%
Back Pain: 6 people, 27.27%
Insomnia (sleeplessness): 5 people, 22.73%
Nausea (feeling of having an urge to vomit): 4 people, 18.18%
Confusional State: 4 people, 18.18%
Dyspnea (difficult or laboured breathing): 4 people, 18.18%
Headache (pain in head): 4 people, 18.18%
Speech Disorder: 4 people, 18.18%
Joint Pain: 3 people, 13.64%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 13.64%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 11 people, 50.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 13.64%
Prostate Cancer Stage Iv: 2 people, 9.09%
High Blood Pressure: 2 people, 9.09%
Urination - Excessive At Night: 2 people, 9.09%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 4.55%
Prostate Cancer: 1 person, 4.55%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 4.55%
Peripheral Swelling: 1 person, 4.55%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Savaysa and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Savaysa:

Savaysa (967 reports)

Weakness treatments and more:

Weakness (586,877 reports)

Browse all side effects of Savaysa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,638 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,617 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on edoxaban tosylate (the active ingredients of Savaysa) and Savaysa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.